Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

SHE:002294 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	53,634	34,481	35,644	36,225	30,220	29,138
Market Cap Growth	15.20%	-3.26%	-1.60%	19.87%	3.71%	39.70%
Enterprise Value	51,123	32,688	33,898	33,154	27,017	28,494
Last Close Price	48.11	30.53	31.66	31.41	25.63	26.58
PE Ratio	89.09	57.32	61.45	56.86	56.62	478.73
Forward PE	78.87	51.55	58.32	54.75	27.88	27.78
PS Ratio	13.46	8.59	10.59	10.40	9.88	10.64
PB Ratio	5.99	3.94	4.43	4.54	3.76	5.21
P/TBV Ratio	7.03	4.68	5.33	5.24	4.38	6.98
P/FCF Ratio	113.49	61.42	211.61	97.42	43.02	39.81
P/OCF Ratio	47.65	29.07	42.46	37.32	25.50	21.20
PEG Ratio	-	1.15	1.15	1.15	1.15	1.15
EV/Sales Ratio	12.83	8.15	10.07	9.52	8.83	10.41
EV/EBITDA Ratio	48.28	31.29	37.95	37.95	33.84	51.59
EV/EBIT Ratio	75.60	47.79	59.91	58.62	53.57	93.03
EV/FCF Ratio	108.17	58.22	201.24	89.16	38.46	38.93
Debt / Equity Ratio	0.02	0.02	0.01	0.03	0.01	0.07
Debt / EBITDA Ratio	0.14	0.13	0.07	0.24	0.10	0.71
Debt / FCF Ratio	0.32	0.24	0.38	0.56	0.11	0.53
Asset Turnover	0.39	0.40	0.35	0.37	0.38	0.37
Inventory Turnover	2.21	2.28	2.06	2.08	2.00	1.90
Quick Ratio	3.09	3.09	3.40	2.56	3.88	1.49
Current Ratio	4.23	3.62	4.07	2.94	4.35	1.94
Return on Equity (ROE)	7.08%	7.20%	7.25%	7.92%	7.75%	0.82%
Return on Assets (ROA)	4.17%	4.30%	3.69%	3.72%	3.90%	2.61%
Return on Capital (ROIC)	4.86%	5.03%	4.34%	4.33%	4.47%	2.95%
Return on Capital Employed (ROCE)	7.10%	7.30%	6.60%	6.90%	6.10%	5.30%
Earnings Yield	1.12%	1.75%	1.63%	1.76%	1.77%	0.21%
FCF Yield	0.88%	1.63%	0.47%	1.03%	2.33%	2.51%
Dividend Yield	1.04%	1.64%	1.58%	1.59%	1.56%	-
Payout Ratio	90.76%	90.77%	94.71%	69.25%	2.91%	878.69%
Buyback Yield / Dilution	0.18%	0.13%	-1.55%	-2.90%	-5.23%	3.55%
Total Shareholder Return	1.22%	1.77%	0.02%	-1.31%	-3.67%	3.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.